A New Prognostic Signature Constructed with Necroptosis-Related lncRNA in Bladder Cancer

Figure 3

Prognostic value of the signature in the training, test, and entire set. (a–c) The distributions of the risk score in the training, test, and entire set, respectively. (d–f) The survival time and survival status of the patients in training, test, and entire set, respectively. (g–i) Heatmaps of 7 NRlncRNAs expression in BC in the training, test, and entire set, respectively. (j–l) Kaplan–Meier curves showed the overall survival between the low-risk group and the high-risk group in the training, test, and entire set, respectively ().

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)